RecruitingPhase 2Phase 3NCT04031456

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

Investigating Reactivation of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in POI Patients

Sponsor

Genesis Athens Clinic

Enrollment

100 participants

Start Date

Jul 30, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve patients' hormonal profile in patients presenting with POI.

Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 39 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Autologous Platelet Rich Plasma and a biological treatment called Placebo-Platelet Free Plasma for people with menopausal syndrome, menopause related conditions, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 25 Years to 39 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.